• Phare
  • Validé par KD/KO

Anticorps Polyclonal de lapin anti-Dystroglycan

Dystroglycan Polyclonal Antibody for FC, IF, IHC, IP, WB, ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain, rat, souris

Applications

WB, IP, IHC, IF, FC, CoIP, ELISA

Conjugaison

Non conjugué

N° de cat : 11017-1-AP

Synonymes

156DAG, A3a, AGRNR, Alpha DG Beta dystroglycan, Alpha-Dystroglycan, Beta DG, Beta dystroglycan, Beta-dystroglycan, DAG, DAG1, Dystroglycan



Applications testées

Résultats positifs en WBcellules HepG2, cellules HeLa, tissu cérébral de souris, tissu de muscle squelettique de souris
Résultats positifs en IPtissu cérébral de souris,
Résultats positifs en IHCtissu cardiaque de souris, tissu cérébral de souris, tissu de muscle squelettique de souris
il est suggéré de démasquer l'antigène avec un tampon de TE buffer pH 9.0; (*) À défaut, 'le démasquage de l'antigène peut être 'effectué avec un tampon citrate pH 6,0.
Résultats positifs en IFcellules HeLa
Résultats positifs en cytométriecellules HeLa,

Dilution recommandée

ApplicationDilution
Western Blot (WB)WB : 1:5000-1:50000
Immunoprécipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Immunohistochimie (IHC)IHC : 1:50-1:500
Immunofluorescence (IF)IF : 1:10-1:100
Flow Cytometry (FC)FC : 0.40 ug per 10^6 cells in a 100 µl suspension
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Informations sur le produit

11017-1-AP cible Dystroglycan dans les applications de WB, IP, IHC, IF, FC, CoIP, ELISA et montre une réactivité avec des échantillons Humain, rat, souris

Réactivité Humain, rat, souris
Réactivité citéerat, Humain, souris
Hôte / Isotype Lapin / IgG
Clonalité Polyclonal
Type Anticorps
Immunogène Dystroglycan Protéine recombinante Ag1456
Nom complet dystroglycan 1 (dystrophin-associated glycoprotein 1)
Masse moléculaire calculée 97 kDa
Poids moléculaire observé 40-43 kDa
Numéro d’acquisition GenBankBC012740
Symbole du gène DAG1
Identification du gène (NCBI) 1605
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par affinité contre l'antigène
Tampon de stockage PBS avec azoture de sodium à 0,02 % et glycérol à 50 % pH 7,3
Conditions de stockageStocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA.

Informations générales

Dystroglycan, also known as DAG1 or DG, was originally isolated from skeletal muscle as an integral membrane component of the dystrophin-glycoprotein complex (DGC). In addition to skeletal muscle, dystroglycan is strongly expressed in heart and smooth muscle, as well as many non-muscle tissues including brain and peripheral nerve (PMID: 12556455). The dystroglycan is involved in a number of processes including laminin and basement membrane assembly, sarcolemmal stability, cell survival, peripheral nerve myelination, nodal structure, cell migration, and epithelial polarization. Dystroglycan consists of two subunits (alpha and beta), which are translated from a single mRNA as a propeptide that is proteolytically cleaved into two noncovalently associated proteins (PMID: 16410545). Alpha-dystroglycan is a 156-kDa extracellular peripheral glycoprotein, while beta-dystroglycan is a 43-kDa transmembrane protein (PMID: 9858474). The 43-kDa beta-dystroglycan can be cleaved into a ~30-kDa form (PMID: 14678802; 18458097; 17255331).

Protocole

Product Specific Protocols
WB protocol for Dystroglycan antibody 11017-1-APDownload protocol
IHC protocol for Dystroglycan antibody 11017-1-APDownload protocol
IF protocol for Dystroglycan antibody 11017-1-APDownload protocol
IP protocol for Dystroglycan antibody 11017-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
mouseIHC

Nat Commun

IL-20 antagonist suppresses PD-L1 expression and prolongs survival in pancreatic cancer models.

Authors - Shao-Wei Lu
mouseWB

Transl Res

AAV-based gene therapy prevents and halts the progression of dilated cardiomyopathy in a mouse model of phosphoglucomutase I deficiency (PGM1-CDG)

Authors - B Balakrishnan
humanWB

Mol Oncol

Circular RNA circ-TNRC6B inhibits the proliferation and invasion of esophageal squamous cell carcinoma cells by regulating the miR-452-5p/DAG1 axis

Authors - Ruiyu Xu
humanWB

Cell Commun Signal

Wnt-driven LARGE2 mediates laminin-adhesive O-glycosylation in human colonic epithelial cells and colorectal cancer.

Authors - Vanessa Dietinger
mouseIHC

Front Cardiovasc Med

Determination of Agrin and Related Proteins Levels as a Function of Age in Human Hearts.

Authors - Katie L Skeffington
humanIHC

J Med Virol

Identification of potential plasma markers for hepatitis B virus-related chronic hepatitis and liver fibrosis/cirrhosis.

Authors - Dandan Zhao

Avis

The reviews below have been submitted by verified Proteintech customers who received an incentive forproviding their feedback.


FH

Perrin (Verified Customer) (11-22-2022)

Works very well, with little background

  • Applications: Immunofluorescence
  • Primary Antibody Dilution: 1 to 100
  • Cell Tissue Type: Gut slice, whole mount
FH

Ryan (Verified Customer) (01-10-2018)

  • Applications: Immunohistochemistry,
  • Primary Antibody Dilution: 1:100
  • Cell Tissue Type: Zebrafish Retina
Dystroglycan Antibody Immunohistochemistry, validation (1:100 dilution) in Zebrafish Retina (Cat no:11017-1-AP)